Iodinated Radiographic Contrast Media Possess Antioxidant Properties in vitro

References

• Almén T. Visipaque – a step forward. A historical review. Acta Radiol 1995; 36: 2–18
   Google Scholar
• Almén T., Golman K. Contrast media pharmacokinetics in the assessment of renal failure. Contrast media: biologic effects and clinical application, Z Parvez, R Moncada, M Sovak. CRC Press, , Florida 1985; 77, In
   Google Scholar
• Andrew E., Berg K. J. Nephrotoxic effects of X-ray contrast media. J Toxicol Clin Toxicol 2004; 42: 325–32
   PubMed Web of Science ®Google Scholar
• Aspelin P., Aubrey P., Fransson S. G., Strasser R., Willenbrock R., Berg K. J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–9
   PubMed Web of Science ®Google Scholar
• Bae K. T., Hong C., Whiting B. R. Radiation dose in multidetector row computed tomography cardiac imaging. J Magn Reson Imaging 2004; 19: 859–63
   PubMed Web of Science ®Google Scholar
• Bakris G. L., Lass N., Gaber A. O., Jones J. D., Burnett JC J. r. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990; 258: F115–20
   PubMed Web of Science ®Google Scholar
• Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 319–25
   PubMed Web of Science ®Google Scholar
• Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276–87
   PubMed Web of Science ®Google Scholar
• Best P. J., Lennon R., Ting H. H., Bell M. R., Rihal C. S., Holmes D. R., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113–19
   PubMed Web of Science ®Google Scholar
• Cracowski J. L., Devillier P., Durand T., Stanke-Labesque F., Bessard G. Vascular biology of the isoprostanes. J Vasc Res 2001; 38: 93–103
   PubMed Web of Science ®Google Scholar
• Darr D., Zarilla K. A., Fridovich I. A mimic of superoxide dismutase activity based upon desferrioxamine B and manganese(IV). Arch Biochem Biophys 1987; 258: 351–5
   PubMed Web of Science ®Google Scholar
• Davidson C. J., Laskey W. K., Hermiller J. B., Harrison J. K., Matthai W J. r., Vlietstra R. E., et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000; 101: 2172–7
   PubMed Web of Science ®Google Scholar
• Dawson P., Edgerton D. Contrast media and enzyme inhibition. I. Cholinesterase. Br J Radiol 1983; 56: 653–6
   PubMedGoogle Scholar
• Diaz-Sandoval L. J., Kosowsky B. D., Losordo D. W. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89: 356–8
   PubMed Web of Science ®Google Scholar
• Ellman G. L., Courtney K. D., Andres V., Featherstone R. M. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95
   PubMed Web of Science ®Google Scholar
• Floyd R. A., Watson J. J., Wong P. K. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Meth 1984; 10: 221–35
   PubMedGoogle Scholar
• Gillbe C. E., Sage F. J., Gutteridge J. M. Commentary: mannitol: molecule magnifique or a case of radical misinterpretation?. Free Radic Res 1996; 24: 1–7
   PubMed Web of Science ®Google Scholar
• Goldstein S., Czapski G. Mannitol as an OH. scavenger in aqueous solutions and in biological systems. Int J Radiat Biol Relat Stud Phys Chem Med 1984; 46: 725–9
   PubMed Web of Science ®Google Scholar
• Grines C. L., Schreiber T. L., Savas V., Jones D. E., Zidar F. J., Gangadharan V., et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 27: 1381–6
   PubMedGoogle Scholar
• Gruberg L., Mintz G. S., Mehran R., Gangas G., Lansky A. J., Kent K. M., et al. The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542–8
   PubMed Web of Science ®Google Scholar
• Gryglewski R. J., Palmer R. M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454–6
   PubMed Web of Science ®Google Scholar
• Hutcheson I. R., Griffith T. M., Pitman M. R., Towart R., Gregersen M., Refsum H., et al. Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 1999; 128: 451–7
   PubMed Web of Science ®Google Scholar
• Karlsson J. O. G. Preclinical safety assessment of contrast media: predictive value. Eur Radiol 1996; Suppl 2: S3
   Google Scholar
• Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621–8
   PubMed Web of Science ®Google Scholar
• Katholi R. E., Woods WT J. r., Taylor G. J., Deitrick C. L., Womack K. A., Katholi C. R., et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32: 64–71
   PubMed Web of Science ®Google Scholar
• Katzberg R. W. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204: 297–312
   PubMed Web of Science ®Google Scholar
• Krause W., Niehues D. Biochemical characterization of X-ray contrast media. Invest Radiol 1996; 31: 30–42
   PubMedGoogle Scholar
• Lasser E. C., Lang J. H. Inhibition of acetylcholinesterase by some organic contrast media. A preliminary communication. Invest Radiol 1966; 1: 237–42
   PubMedGoogle Scholar
• Miller N. J., Rice-Evans C., Davies M. J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Colch) 1993; 84: 407–12
   Google Scholar
• Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42
   PubMed Web of Science ®Google Scholar
• Morrow J. D., Hill K. E., Burk R. F., Nammour T. M., Badr K. F., Roberts L. J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383–7
   PubMed Web of Science ®Google Scholar
• Morrow J. D., Roberts L. J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36: 1–21
   PubMed Web of Science ®Google Scholar
• Mugge A., Elwell J. H., Peterson T. E., Harrison D. G. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 1991; 260: C219–25
   PubMed Web of Science ®Google Scholar
• Nikolsky E., Mehran R. Understanding the consequences of contrast-induced nephropathy. Rev Cardiovasc Med 2003; Suppl 5: S10
   Google Scholar
• Onodera T., Ashraf M. Detection of hydroxyl radicals in the post-ischemic reperfused heart using salicylate as a trapping agent. J Mol Cell Cardiol 1991; 23: 365–70
   PubMed Web of Science ®Google Scholar
• Parvez Z., Rahman M. A., Moncada R. Contrast media-induced lipid peroxidation in the rat kidney. Invest Radiol 1989; 24: 697–702
   PubMedGoogle Scholar
• Patrono C., FitzGerald G. A. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997; 17: 2309–15
   PubMed Web of Science ®Google Scholar
• Pitman M. R., Karlsson J. O. G., Griffith T. M. Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta. Br J Pharmacol 1996; 119: 685–90
   PubMedGoogle Scholar
• Rubanyi G. M., Vanhoutte P. M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250: H822–7
   PubMed Web of Science ®Google Scholar
• Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998; 53: 230–42
   PubMed Web of Science ®Google Scholar
• Spitz D. R., Oberley L. W. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989; 179: 8–18
   PubMed Web of Science ®Google Scholar
• Stokes K. Y., Granger D. N. Role of nitric oxide in ischemia-reperfusion injury. Nitric oxide: biology and pathobiology, L. J Ignarro. Academic Press, San Diego 2000; 633, In
   Google Scholar
• Strube M., Haenen G. R., van den Berg H., Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997; 26: 515–21
   PubMed Web of Science ®Google Scholar
• Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180–4
   PubMed Web of Science ®Google Scholar
• Yoshioka T., Fogo A., Beckman J. K. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992; 41: 1008–15
   PubMed Web of Science ®Google Scholar